Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-29

Clinical Trial Update: Ketamine and Neuropathic Pain [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial evaluating ketamine for neuropathic pain, with the trial's current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Neuropathic Pain | Phase 2 | Status: UNKNOWN